Norsk biobank for myelomatose Følgeforskning
- Prosjektnummer
- 46060909
- Ansvarlig person
- Anders Waage
- Institusjon
- St. Olavs Hospital
- Prosjektkategori
- Flerårig prosjekt 2011-SO
- Helsekategori
- Blood, Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients.
Biomark Res 2014;2(1):8. Epub 2014 apr 9
PMID: 24716444
Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.
Blood Cancer J 2014;4():e196. Epub 2014 mar 21
PMID: 24658374
A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells.
J Biomol Screen 2013 Jul;18(6):637-46. Epub 2013 feb 27
PMID: 23446700
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
Eur J Haematol 2013 Oct;91(4):339-46. Epub 2013 aug 20
PMID: 23869695
Addiction to c-MYC in multiple myeloma.
Blood 2012 Sep;120(12):2450-3. Epub 2012 jul 17
PMID: 22806891
Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease.
Histopathology 2012 Feb;60(3):443-51.
PMID: 22276607
Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.
Leukemia 2012 May;26(5):1073-80. Epub 2011 sep 23
PMID: 21941367
Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.
Leukemia 5:1073-80; 2012. PMID21941367
Addiction to c-MYC in multiple myeloma.
Blood 120:2450-3; 2012. PMID: 22806891
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
Eur J Haematol. 2013,91:339-46. PMID:23869695
HGF and IGF-1 synergize with SDF-1a in promoting migration of myeloma cells by cooperative activation of p21-activated kinase.
Exp Hematol. 2013;41:646-55. PMID: 23499762
A method for measurement of drug sensitivity of myeloma cells co cultured with bone marrow stromal cells.
J Biomed Scr, 18:637-46;2013. PMID23446700
Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma.
Leukemia and Lymphoma 9;1-28;2015. PMID 25573204
Soluble c-Met in serum of multiple myeloma patients: correlation with clinical parameters.
Eur J Haematol. 87:394-9,2011. PMID: 21466586
Hepatocyte growth factor and Phosphatase of Regenerating Liver 3 in multiple myeloma
- Disputert:
- januar 2014
- Hovedveileder:
- Anders Sundan
Potdoktor
- Disputert:
- februar 2012
- Hovedveileder:
- Anders Sundan
- Therese Standal Forskningsgruppeleder
- Magne Børset Forskningsgruppeleder
- Anders Sundan Forskningsgruppeleder
- Anders Waage Prosjektleder
- Holien Toril Postdoktorstipendiat
- Misund Kristine Postdoktorstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU